Black Diamond Therapeutics Inc. (NASDAQ: BDTX)
$6.10
+0.0800 ( +1.33% ) 99.2K
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
Market Data
Open
$6.10
Previous close
$6.02
Volume
99.2K
Market cap
$344.36M
Day range
$5.89 - $6.22
52 week range
$1.62 - $7.66
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 2 | Apr 03, 2024 |
4 | Insider transactions | 1 | Apr 03, 2024 |
10-k | Annual reports | 86 | Mar 12, 2024 |
8-k | 8K-related | 16 | Mar 12, 2024 |
4 | Insider transactions | 1 | Feb 15, 2024 |
4 | Insider transactions | 1 | Feb 15, 2024 |
4 | Insider transactions | 1 | Feb 15, 2024 |
4 | Insider transactions | 1 | Feb 15, 2024 |
4 | Insider transactions | 1 | Feb 15, 2024 |
4 | Insider transactions | 1 | Feb 15, 2024 |